|
Volumn 21, Issue 1, 2017, Pages 123-124
|
Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ISONIAZID;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ANTIBIOTIC RESISTANCE;
BANGLADESH;
DRUG BLOOD LEVEL;
DRUG INDICATION;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG TOLERABILITY;
GENE;
GENE MUTATION;
HUMAN;
INHA GENE;
KATG GENE;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANT TUBERCULOSIS;
PRIORITY JOURNAL;
MYCOBACTERIUM TUBERCULOSIS;
ANTITUBERCULAR AGENTS;
HUMANS;
ISONIAZID;
MYCOBACTERIUM TUBERCULOSIS;
RIFAMPIN;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
|
EID: 85007587071
PISSN: 10273719
EISSN: 18157920
Source Type: Journal
DOI: 10.5588/ijtld.16.0619 Document Type: Letter |
Times cited : (22)
|
References (6)
|